Following the successful start of clinical cadaveric trials in June 2016, investment proceeds will enable CMR to continue on its path toward becoming a global medical device manufacturer. Specifically, the proceeds will be used to advance development and commercialization of its medical robotic technology, and to expand the team in preparation for regulatory approval.
"As CMR prepares for its next phase of development, the company will benefit enormously from this strong and diverse investor group that includes a leading global player in the robotics field (ABB), and some of the best known institutional investors in Europe," said Victor Garcia, Managing Director at Mooreland.
ABOUT MOORELAND PARTNERS
Founded in 2002, Mooreland Partners is a leading independent investment bank providing M&A and private capital advisory services to the global technology industry, serving clients from its offices in London, New York, and Silicon Valley. Mooreland's team of nearly 50 professionals delivers industry domain and transaction expertise across all major technology sectors including industrial technology and electronics, enterprise software and services, communications technology, as well as digital media and internet. Learn more at www.moorelandpartners.com; read our blog.
All trademarks contained herein are the property of their respective owners.
Tel. +1 212 653 0800
Logo - http://photos.prnewswire.com/prnh/20141029/155139LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/mooreland-partners-advises-cambridge-medical-robotics-on-its-20-million-series-a-financing-300300017.html
SOURCE Mooreland Partners